Mv Capital Management, Inc. Madrigal Pharmaceuticals, Inc. Call Options Transaction History
Mv Capital Management, Inc.
- $931 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MDGL
# of Institutions
365Shares Held
23.3MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$904 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$862 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$822 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$815 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$774 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...